High blood pressure? Consider hyperaldosteronism
It is estimated that primary hyperaldosteronism is the cause of hypertension in as much as 5 per cent of patients. This article focuses of the two most common forms of this condition.
Early detection and treatment of primary hyperaldosteronism will improve morbidity and mortality, particularly because it means that stubborn hypertension can be managed in the optimal way. This article discusses signs and symptoms to look out for, diagnosis and management, which includes surgery. It focuses on drug treatment with spironolactone or eplerenone.
To read the full article download the PDF above
Nadhia Bashir ClinDip, MRPharmS, specialist clinical pharmacist, Scott Akker MRCP, PhD, consultant endocrinologist, and Hasanin Khachi iPresc, MRPharmS, highly specialist pharmacist — specialist medicine, are all at Barts Health NHS Trust.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2013.11121258
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com